Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis
Article first published online: 30 AUG 2013
Copyright © 2013 John Wiley & Sons, Ltd.
Special Issue: Bayesian Methods in Drug Development and Regulatory Review
Volume 13, Issue 1, pages 55–70, January/Febuary 2014
How to Cite
Ohlssen, D., Price, K. L., Amy Xia, H., Hong, H., Kerman, J., Fu, H., Quartey, G., Heilmann, C. R., Ma, H. and Carlin, B. P. (2014), Guidance on the implementation and reporting of a drug safety Bayesian network meta-analysis. Pharmaceut. Statist., 13: 55–70. doi: 10.1002/pst.1592
- Issue published online: 21 JAN 2014
- Article first published online: 30 AUG 2013
- Manuscript Accepted: 1 AUG 2013
- Manuscript Revised: 3 JUL 2013
- Manuscript Received: 25 JAN 2013
Options for accessing this content:
- If you have access to this content through a society membership, please first log in to your society website.
- If you would like institutional access to this content, please recommend the title to your librarian.
- Login via other institutional login options http://onlinelibrary.wiley.com/login-options.
- You can purchase online access to this Article for a 24-hour period (price varies by title)
- New Users: Please register, then proceed to purchase the article.
Login via OpenAthens
Search for your institution's name below to login via Shibboleth.
Registered Users please login:
- Access your saved publications, articles and searches
- Manage your email alerts, orders and subscriptions
- Change your contact information, including your password
Please register to:
- Save publications, articles and searches
- Get email alerts
- Get all the benefits mentioned below!